Three U.S. Senators have proposed legislation that would further regulate the administration of antipsychotic medications to nursing home residents. Specifically, the new measure would require nursing home staff to obtain informed consent from residents or their legally designated representative that acknowledges possible risks and side effects. The measure addresses growing public concern about “off label” uses for such medications.